Embecta, a global leader in medical technology innovation, has been named Healthcare Technology Company of the Year at the prestigious NYC Awards Night hosted by The Healthcare Technology Report on March 6, 2025. The accolade celebrates embecta’s transformative contributions to advancing patient care through cutting-edge medical devices and digital health solutions.
The annual event brought together top executives, founders, and investors from the healthcare, software, and financial technology sectors. Tom Blount, Senior Vice President and President of North America at embecta, accepted the award on behalf of the company, highlighting its commitment to improving lives worldwide.
A Legacy of Innovation and Impact
Embecta supports millions of patients globally with its pioneering technologies, which address critical healthcare challenges such as diabetes management, chronic disease care, and medication delivery. Despite navigating macroeconomic headwinds—including inflationary pressures, supply chain disruptions, and geopolitical instability—embecta has maintained unwavering dedication to the 30 million individuals who rely on its products daily.
Rigorous Selection Process
The award was determined through a multi-phase evaluation, incorporating nominations, independent research, and a final vote by a committee of industry experts. Criteria included technological innovation, market influence, and measurable improvements in patient outcomes.
“This recognition reflects the relentless efforts of our team to push boundaries in healthcare technology,” said Tom Blount. “Our mission has always been to empower patients and providers with solutions that enhance quality of life, and this award reinforces the impact of that work.”
Driving the Future of Healthcare
Embecta continues to lead the industry by integrating advanced digital tools with user-centric medical devices, ensuring accessibility and efficacy in an evolving global healthcare landscape. The company’s focus on scalable, sustainable solutions positions it as a critical player in shaping the future of patient care.
